Abstract

Acute renal failure (ARF) is associated with high morbidity and mortality both during the acute episode and long term. Proper management is to identify patients at risk of suffering (old age, chronic kidney disease and heart failure) and understand the factors that can trigger the IRA, avoiding those that are modifiable (NSAIDs, ACE inhibitors, ARBs) and assessing the risk / benefit of diagnostic actions (iodinated contrast agents) and therapeutic as heart surgery or the use of medications that may affect renal function. General aspects of primary and secondary prevention where adequate control of blood volume, along with the use of vasoactive drugs on hemodynamic IRA origin and prevention of nephrotoxicity in toxic causes are the backbone of treatment are discussed the IRA complete with the measures to take to functional recovery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call